S&P 500   3,856.86
DOW   31,191.03
QQQ   324.18
S&P 500   3,856.86
DOW   31,191.03
QQQ   324.18
S&P 500   3,856.86
DOW   31,191.03
QQQ   324.18
S&P 500   3,856.86
DOW   31,191.03
QQQ   324.18
Log in
NYSE:TMO

Thermo Fisher Scientific Stock Forecast, Price & News

$515.76
+8.38 (+1.65 %)
(As of 01/20/2021 03:21 PM ET)
Add
Compare
Today's Range
$509.50
Now: $515.76
$519.74
50-Day Range
$457.79
MA: $477.58
$513.35
52-Week Range
$250.21
Now: $515.76
$532.57
Volume47,356 shs
Average Volume1.90 million shs
Market Capitalization$204.41 billion
P/E Ratio42.28
Dividend Yield0.17%
Beta0.85
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; an agreement with Daiichi Sankyo; and collaboration with Northeastern University. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific logo

MarketRank

Overall MarketRank

1.99 out of 5 stars

Medical Sector

55th out of 1,928 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

2nd out of 19 stocks

Analyst Opinion: 2.4Community Rank: 3.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000
Employees75,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25.54 billion
Cash Flow$18.59 per share
Book Value$74.00 per share

Profitability

Net Income$3.70 billion

Miscellaneous

Market Cap$204.41 billion
Next Earnings Date2/1/2021 (Confirmed)
OptionableOptionable
$515.76
+8.38 (+1.65 %)
(As of 01/20/2021 03:21 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

How has Thermo Fisher Scientific's stock been impacted by COVID-19 (Coronavirus)?

Thermo Fisher Scientific's stock was trading at $289.38 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TMO shares have increased by 78.9% and is now trading at $517.79.
View which stocks have been most impacted by COVID-19
.

Is Thermo Fisher Scientific a buy right now?

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 4 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Thermo Fisher Scientific stock.
View analyst ratings for Thermo Fisher Scientific
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Thermo Fisher Scientific?

Wall Street analysts have given Thermo Fisher Scientific a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Thermo Fisher Scientific wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Thomas Greco's approval rating as Thermo Fisher Scientific's CEO?

538 employees have rated Thermo Fisher Scientific CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among Thermo Fisher Scientific's employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release its next quarterly earnings announcement on Monday, February 1st 2021.
View our earnings forecast for Thermo Fisher Scientific
.

How can I listen to Thermo Fisher Scientific's earnings call?

Thermo Fisher Scientific will be holding an earnings conference call on Monday, February 1st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) issued its quarterly earnings results on Wednesday, October, 21st. The medical research company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $4.37 by $1.26. The medical research company had revenue of $8.25 billion for the quarter, compared to the consensus estimate of $7.68 billion. Thermo Fisher Scientific had a return on equity of 21.35% and a net margin of 17.12%. The firm's revenue for the quarter was up 31.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.94 EPS.
View Thermo Fisher Scientific's earnings history
.

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Thursday, November 5th. Investors of record on Tuesday, December 15th will be paid a dividend of $0.22 per share on Friday, January 15th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date is Monday, December 14th.
View Thermo Fisher Scientific's dividend history
.

Is Thermo Fisher Scientific a good dividend stock?

Thermo Fisher Scientific pays an annual dividend of $0.88 per share and currently has a dividend yield of 0.17%. Thermo Fisher Scientific has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Thermo Fisher Scientific is 7.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 4.41% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.
View Thermo Fisher Scientific's dividend history.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific declared that its board has approved a stock buyback program on Thursday, November 5th 2020, which permits the company to buyback $2,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 1.2% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific updated its fourth quarter 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10.244-10.244 billion, compared to the consensus revenue estimate of $9.4 billion.

What price target have analysts set for TMO?

20 Wall Street analysts have issued 1 year price targets for Thermo Fisher Scientific's stock. Their forecasts range from $340.00 to $580.00. On average, they anticipate Thermo Fisher Scientific's stock price to reach $492.83 in the next twelve months. This suggests that the stock has a possible downside of 4.8%.
View analysts' price targets for Thermo Fisher Scientific
or view Wall Street analyst' top-rated stocks.

Who are some of Thermo Fisher Scientific's key competitors?

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Thermo Fisher Scientific investors own include Johnson & Johnson (JNJ), The Home Depot (HD), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Honeywell International (HON), The Walt Disney (DIS), CVS Health (CVS), Visa (V) and The Procter & Gamble (PG).

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the following people:
  • Mr. Marc N. Casper, Chairman, Pres & CEO (Age 52, Pay $6.27M)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 53, Pay $1.74M)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 57, Pay $2.78M)
  • Mr. Syed A. Jafry, Sr. VP & Pres of Regions (Age 56, Pay $1.26M)
  • Mr. Michel Lagarde, Exec. VP (Age 45, Pay $2.28M)
  • Mr. Peter E. Hornstra, VP & Chief Accounting Officer (Age 60)
  • Mr. Ryan J. Snyder, Sr. VP & Chief Information Officer
  • Mr. Kenneth J. Apicerno, VP of Investor Relations
  • Mr. Michael A. Boxer Esq., Sr. VP & Gen. Counsel (Age 58)
  • Ms. Sandy Pound, VP & Chief Communications Officer

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Gofen & Glossberg LLC IL (0.07%), Douglas Lane & Associates LLC (0.07%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.06%), Manning & Napier Group LLC (0.05%), DNB Asset Management AS (0.04%) and Gateway Investment Advisers LLC (0.04%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Mark Stevenson, Peter E Hornstra, Stephen Williamson and Syed A Jafry.
View institutional ownership trends for Thermo Fisher Scientific
.

Which major investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Manning & Napier Group LLC, Huntington National Bank, Douglas Lane & Associates LLC, Transform Wealth LLC, Gateway Investment Advisers LLC, Addenda Capital Inc., and Gofen & Glossberg LLC IL. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include Jim P Manzi, Marc N Casper, Mark Stevenson, Peter E Hornstra, Stephen Williamson, and Syed A Jafry.
View insider buying and selling activity for Thermo Fisher Scientific
or view top insider-selling stocks.

Which major investors are buying Thermo Fisher Scientific stock?

TMO stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, Exchange Traded Concepts LLC, James Hambro & Partners, IFM Investors Pty Ltd, Louisiana State Employees Retirement System, Sheets Smith Wealth Management, and HBW Advisory Services LLC.
View insider buying and selling activity for Thermo Fisher Scientific
or or view top insider-buying stocks.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $517.79.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $205.22 billion and generates $25.54 billion in revenue each year. The medical research company earns $3.70 billion in net income (profit) each year or $12.35 on an earnings per share basis. Thermo Fisher Scientific employs 75,000 workers across the globe.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is www.thermofisher.com.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.